Cargando…

NR5A1 gene variants repress the ovarian‐specific WNT signaling pathway in 46,XX disorders of sex development patients

Several recent reports have described a missense variant in the gene NR5A1 (c.274C>T; p.Arg92Trp) in a significant number of 46,XX ovotesticular or testicular disorders of sex development (DSDs) cases. The affected residue falls within the DNA‐binding domain of the NR5A1 protein, however the exac...

Descripción completa

Detalles Bibliográficos
Autores principales: Knarston, Ingrid M., Robevska, Gorjana, van den Bergen, Jocelyn A, Eggers, Stefanie, Croft, Brittany, Yates, Jason, Hersmus, Remko, Looijenga, Leendert H. J., Cameron, Fergus J., Monhike, Klaus, Ayers, Katie L., Sinclair, Andrew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492147/
https://www.ncbi.nlm.nih.gov/pubmed/30350900
http://dx.doi.org/10.1002/humu.23672
_version_ 1783415091682607104
author Knarston, Ingrid M.
Robevska, Gorjana
van den Bergen, Jocelyn A
Eggers, Stefanie
Croft, Brittany
Yates, Jason
Hersmus, Remko
Looijenga, Leendert H. J.
Cameron, Fergus J.
Monhike, Klaus
Ayers, Katie L.
Sinclair, Andrew H.
author_facet Knarston, Ingrid M.
Robevska, Gorjana
van den Bergen, Jocelyn A
Eggers, Stefanie
Croft, Brittany
Yates, Jason
Hersmus, Remko
Looijenga, Leendert H. J.
Cameron, Fergus J.
Monhike, Klaus
Ayers, Katie L.
Sinclair, Andrew H.
author_sort Knarston, Ingrid M.
collection PubMed
description Several recent reports have described a missense variant in the gene NR5A1 (c.274C>T; p.Arg92Trp) in a significant number of 46,XX ovotesticular or testicular disorders of sex development (DSDs) cases. The affected residue falls within the DNA‐binding domain of the NR5A1 protein, however the exact mechanism by which it causes testicular development in 46,XX individuals remains unclear. We have screened a cohort of 26 patients with 46,XX (ovo)testicular DSD and identified three unrelated individuals with this NR5A1 variant (p.Arg92Trp), as well as one patient with a novel NR5A1 variant (c.779C>T; p.Ala260Val). We examined the functional effect of these changes, finding that while protein levels and localization were unaffected, variant NR5A1 proteins repress the WNT signaling pathway and have less ability to upregulate the anti‐testis gene NR0B1. These findings highlight how NR5A1 variants impact ovarian differentiation across multiple pathways, resulting in a switch from ovarian to testis development in genetic females.
format Online
Article
Text
id pubmed-6492147
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64921472019-05-06 NR5A1 gene variants repress the ovarian‐specific WNT signaling pathway in 46,XX disorders of sex development patients Knarston, Ingrid M. Robevska, Gorjana van den Bergen, Jocelyn A Eggers, Stefanie Croft, Brittany Yates, Jason Hersmus, Remko Looijenga, Leendert H. J. Cameron, Fergus J. Monhike, Klaus Ayers, Katie L. Sinclair, Andrew H. Hum Mutat Research Articles Several recent reports have described a missense variant in the gene NR5A1 (c.274C>T; p.Arg92Trp) in a significant number of 46,XX ovotesticular or testicular disorders of sex development (DSDs) cases. The affected residue falls within the DNA‐binding domain of the NR5A1 protein, however the exact mechanism by which it causes testicular development in 46,XX individuals remains unclear. We have screened a cohort of 26 patients with 46,XX (ovo)testicular DSD and identified three unrelated individuals with this NR5A1 variant (p.Arg92Trp), as well as one patient with a novel NR5A1 variant (c.779C>T; p.Ala260Val). We examined the functional effect of these changes, finding that while protein levels and localization were unaffected, variant NR5A1 proteins repress the WNT signaling pathway and have less ability to upregulate the anti‐testis gene NR0B1. These findings highlight how NR5A1 variants impact ovarian differentiation across multiple pathways, resulting in a switch from ovarian to testis development in genetic females. John Wiley and Sons Inc. 2018-11-30 2019-02 /pmc/articles/PMC6492147/ /pubmed/30350900 http://dx.doi.org/10.1002/humu.23672 Text en © 2018 The Authors. Human Mutation published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Knarston, Ingrid M.
Robevska, Gorjana
van den Bergen, Jocelyn A
Eggers, Stefanie
Croft, Brittany
Yates, Jason
Hersmus, Remko
Looijenga, Leendert H. J.
Cameron, Fergus J.
Monhike, Klaus
Ayers, Katie L.
Sinclair, Andrew H.
NR5A1 gene variants repress the ovarian‐specific WNT signaling pathway in 46,XX disorders of sex development patients
title NR5A1 gene variants repress the ovarian‐specific WNT signaling pathway in 46,XX disorders of sex development patients
title_full NR5A1 gene variants repress the ovarian‐specific WNT signaling pathway in 46,XX disorders of sex development patients
title_fullStr NR5A1 gene variants repress the ovarian‐specific WNT signaling pathway in 46,XX disorders of sex development patients
title_full_unstemmed NR5A1 gene variants repress the ovarian‐specific WNT signaling pathway in 46,XX disorders of sex development patients
title_short NR5A1 gene variants repress the ovarian‐specific WNT signaling pathway in 46,XX disorders of sex development patients
title_sort nr5a1 gene variants repress the ovarian‐specific wnt signaling pathway in 46,xx disorders of sex development patients
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492147/
https://www.ncbi.nlm.nih.gov/pubmed/30350900
http://dx.doi.org/10.1002/humu.23672
work_keys_str_mv AT knarstoningridm nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT robevskagorjana nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT vandenbergenjocelyna nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT eggersstefanie nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT croftbrittany nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT yatesjason nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT hersmusremko nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT looijengaleenderthj nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT cameronfergusj nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT monhikeklaus nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT ayerskatiel nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients
AT sinclairandrewh nr5a1genevariantsrepresstheovarianspecificwntsignalingpathwayin46xxdisordersofsexdevelopmentpatients